Successful execution of a new strategy could prove to be rewarding for shareholders. Find out more in the report!
A sharp correction despite fundamentals remaining intact in the case of this Prime Stock!
Find out why this stock is making its way into our BUY list for the second time!
With Trump’s talk of tariffs dominating headlines, if you too have joined in the quest for stocks that may offer immunity from this threat then this vaccine-maker is one of our picks – Glaxosmithkline Pharmaceuticals Limited. This MNC pharma player has an enduring suite of brands that have withstood challenges, such as the advent of […]
Results update for 13 of our Prime Stocks.
This company has built an aspirational brand in a highly profitable niche market!
Just as it seemed like the sector had turned a corner, President Trump’s talk about imposing tariffs of 25% on imports from India has made pharma sector investors sick with worry prompting a sell-off. This tariff, if it does come into force, will affect some players more than others. One of the companies that it […]
This company is turning a boring commodity business into a wealth creation machine for investors!
Results update for 11 of our Prime Stocks.
Times are bright for companies catering to the rural economy and here is one way to play it!
Results update for 9 of our Prime Stocks.
The significant market correction presents a strategic buying opportunity despite current headwinds.
Hold On
You are being redirected to another page,
Elevate Your Wealth with Professional Portfolio Management
